The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Heterocyclic Compounds, 3-Ring

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Heterocyclic Compounds, 3-Ring.
Olatoyosi Odenike
Connection Strength
0.129
Heterocyclic Compounds, 3-Ring
  1. An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia. Leuk Lymphoma. 2016 08; 57(8):1800-6.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.